Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

about

Inhibition of BTK protects lungs from trauma-hemorrhagic shock-induced injury in rats

P2860

Q33827989-55015C5F-6FC9-426A-B2B4-5B16F8473D7D

P2860

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

Item

http://www.wikidata.org/entity/Q26795594

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@ast

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@en

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@nl

type

Item

label

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@ast

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@en

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@nl

prefLabel

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@ast

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@en

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@nl

P1476

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

@en

P2093

Martin Schmidt-Hieber

http://www.w3.org/2001/XMLSchema#string

Nadine Kutsch

http://www.w3.org/2001/XMLSchema#string

Reinhard Marks

http://www.w3.org/2001/XMLSchema#string

Richard Ratei

http://www.w3.org/2001/XMLSchema#string

Thomas K Held

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

Helicobacter pylori infection and gastric lymphoma

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

P304

15-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/BMI.S22434

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

Suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281519182

http://www.w3.org/2001/XMLSchema#string

P698

26327780

http://www.w3.org/2001/XMLSchema#string

P932

4539014

http://www.w3.org/2001/XMLSchema#string

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

about

P2860

P2860

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932